Direct determination of mitoxantrone and its mono- and dicarboxylic metabolites in plasma and urine by high-performance liquid chromatography

This publication has 25 references indexed in Scilit:

• The antitumor agent mitoxantrone binds cooperatively to DNA: evidence for heterogeneity in DNA conformation
  Biochemistry, 1986
• Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1984
• Molecular and biochemical pharmacology of mitoxantrone
  Cancer Treatment Reviews, 1983
• Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone
  Journal of Chromatography B: Biomedical Sciences and Applications, 1982
• High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokinetics
  Life Sciences, 1981
• Clinical analysis for the anti-neoplastic agent 1,4-dihydroxy-5,8-bis{{2-[(2-hydroxyethyl)amino]ethyl}amino} 9,10-anthracenedione dihydrochloride (NSC 301739) in plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1981
• Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drug
  Cancer Chemotherapy and Pharmacology, 1980
• An HPLC Method for the Quantitative Determination of 1,4-Dihydroxy-5,8 Bis [[2-[(2-Hydroxyethyl) Amino] Ethyl] Amino] 9,10 - Anthracenedione (DHAQ, Lederle Labs CL232 315, NCS 301739) in Serum
  Journal of Liquid Chromatography, 1980
• Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones
  Journal of Medicinal Chemistry, 1979